In-Depth Examination Of 6 Analyst Recommendations For Zimmer Biomet Holdings
Portfolio Pulse from Benzinga Insights
In the last three months, six analysts have provided diverse evaluations of Zimmer Biomet Holdings (NYSE:ZBH), ranging from bullish to bearish. The average 12-month price target has increased to $139.17, with a high estimate of $155.00 and a low estimate of $130.00. Recent analyst actions include upgrades and downgrades, reflecting their reactions to market conditions and company performance.
May 21, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Zimmer Biomet Holdings has received mixed analyst ratings over the past three months, with a recent average price target of $139.17. Analysts' actions include both upgrades and downgrades, reflecting varied outlooks on the company's performance.
The mixed analyst ratings and recent changes in price targets indicate a neutral short-term impact on Zimmer Biomet Holdings' stock price. The average price target has slightly increased, but the varied outlooks suggest uncertainty in the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100